Olopatadine hydrochloride & mometasone furoate combination nasal spray for allergic rhinitis & rhinoconjunctivitis

Description

In this Product Explainer, Rhinologist Prof Richard Harvey explains the role of olopatadine hydrochloride and mometasone furoate combination nasal spray in the treatment of symptoms associated with allergic rhinitis and rhinoconjunctivitis in patients 6 years of age and older (5 mins).

This Product Explainer is supported by CSL Seqirus

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
A/Prof Karam Kostner

A/Prof Karam Kostner

LDL Management – Why it is Important

A/Prof Ralph Audehm

A/Prof Ralph Audehm

Navigating Expanded PBS Access to SGLT2i in General Practice

Prof Deborah Bateson

Prof Deborah Bateson

Cervical Cancer Prevention – Common Questions

Clinical A/Prof Greg Katsoulotos

Clinical A/Prof Greg Katsoulotos

Asthma Cases – When to Use Dual vs Triple Therapy

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Richard Harvey

expert

Prof Richard Harvey

Rhinologist; Nose, Sinus, Allergy and Endoscopic Sinus and Skull Base Surgeon

Date published: 24 October 2023